Defective bone repair in mast cell-deficient cpa3Cre/+mice

In the adult skeleton, cells of the immune system interact with those of the skeleton during all phases of bone repair to influence the outcome. Mast cells are immune cells best known for their pathologic role in allergy, and may be involved in chronic inflammatory and fibrotic disorders. Potential roles for mast cells in tissue homeostasis, vascularization and repair remain enigmatic. Previous studies in combined mast cell-and Kit-deficient Kit(w-sh/w-sh) mice (Kit(w-sh)) implicated mast cells in bone repair but Kit(w-sh) mice suffer from additional Kit dependent hematopoietic and non-hematopoietic deficiencies that could have confounded the outcome. The goal of the current study was to compare bone repair in normal wild type (W7) and Cpa3(Cre/+) mice, which lack mast cells in the absence of any other hematopoietic or non-hematopoietic deficiencies. Repair of a femoral window defect was characterized using micro CT imaging and histological analyses from the early inflammatory phase, through soft and hard callus formation, and finally the remodeling phase. The data indicate 1) mast cells appear in healing bone of VVT mice but not Cpa3(Cre/+) mice, beginning 14 days after surgery; 2) re-vascularization of repair tissue and deposition of mineralized bone was delayed and dis-organised in Cpa3(Cre/+) mice compared with WTmice; 3) the defects in Cpa3(Cre/+) mice were associated with little change in anabolic activity and biphasic alterations in osteoclast and macrophage activity. The outcome at 56 days postoperative was complete bridging of the defect in most VVT mice and fibrous mal-union in most Cpa3(Cre/+) mice. The results indicate that mast cells promote bone healing, possibly by recruiting vascular endothelial cells during the inflammatory phase and coordinating anabolic and catabolic activity during tissue remodeling. Taken together the data indicate that mast cells have a positive impact on bone repair.